Global market for drugs to treat immune diseases to reach $82.2 billion by 2015

October 10, 2012

In 2010, the global drug market for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.

Learn about the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system. Get information on of various technology types used to contain undesirable immune responses and drugs in each category, key challenges, players in the market along with company profiles and patent analysis…

Use this report to:

  • Understand how the most prevalent technologies in the immune system disorders therapeutic market have changed over the past decade with the advent of biologics and drugs with novel methods of delivery
  • Identify the various regulatory and market trends that will impact major immune disease segments during the forecast period and how they will influence your future business strategies
  • Examine the current market for the treatment of immune disease and develop effective marketing strategies based on the projected effects of new technologies upon this market
  • Maintain a competitive standing with an in–depth analysis of leading companies and their successful strategies.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR DRUGS TO TREAT IMMUNE DISEASES, 2009-2015
($ MILLIONS)


Source: BCC Research
Advertisements

Global market for drugs to treat immune diseases to reach $82.2 billion by 2015

October 4, 2012

In 2010, the global drug market for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.

Learn about the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system. Get information on of various technology types used to contain undesirable immune responses and drugs in each category, key challenges, players in the market along with company profiles and patent analysis…

Use this report to:

  • Understand how the most prevalent technologies in the immune system disorders therapeutic market have changed over the past decade with the advent of biologics and drugs with novel methods of delivery
  • Identify the various regulatory and market trends that will impact major immune disease segments during the forecast period and how they will influence your future business strategies
  • Examine the current market for the treatment of immune disease and develop effective marketing strategies based on the projected effects of new technologies upon this market
  • Maintain a competitive standing with an in–depth analysis of leading companies and their successful strategies.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR DRUGS TO TREAT IMMUNE DISEASES, 2009-2015
($ MILLIONS)
Source: BCC Research

Global kinase inhibitors market to grow to $40.2 billion by 2016

August 7, 2012

The global kinase inhibitors market reached $28.1 billion in 2010 and nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.

Learn about the present and future strategies within the kinase inhibitors market, which include tyrosine inhibitors, multi-target kinase inhibitors, serine/ threonine inhibitors and monoclonal antibody kinase inhibitors. The direction of the market, its setbacks and needs of the market are also discussed in this report…

Use this report to:

  • Receive an overview of the current and future characteristics of the global market for kinase inhibitors including various applications and also market forecasts
  • Identify potential for additional novel applications and new competitive threats in the market
  • Examine the role of government regulations, patents, and factors affecting the industry worldwide
  • Receive information about technological issues including the latest trends and developments

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

GLOBAL REVENUE OF KINASE INHIBITORS MARKET, 2009-2016

($ MILLIONS)

Global kinase inhibitors market to grow to $40.2 billion by 2016


Next-Generation Cancer Diagnostics: Technologies and Global Markets

July 17, 2012

The total annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.
Learn about the status of next generation cancer diagnostic technologies and assays, and assess their worldwide growth potential over a 5-year period from 2010 to 2015. Influencing factors, including cancer diagnostics needs, regulatory trends, industry structure, and patent status are also discussed…
Use this report to:

  • Characterize the markets for the key next generation platforms: real time polymerase chain reaction, DNA microarrays, lab-on-a-chip, protein microarrays, circulating tumor cells, and multiplexed conventional and next generation sequencing.
  • Understand the trends, markets, applications, industry dynamics, and the forces driving industry growth as the basis for effective strategy development.
  • Evaluate market opportunities and future growth of specific cancer diagnostic market segments to validate or formulate business development plans.
  • Analyze the impact of recent corporate acquisitions and alliances with the potential to change the industry structure and competitive landscape.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL VALUE OF NEXT GENERATION CANCER DIAGNOSTICS BY ANALYSIS TYPE, 2009-2015
($ MILLIONS)


Global Market for Enzyme Inhibitors to Grow to $127.4 Billion by 2016

June 20, 2012

The global market for enzyme inhibitors was valued at $104.4 billion in 2010 and reached nearly $104.6 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 4% and reach nearly $127.4 billion by 2016.

Learn about the enzyme inhibitors in the pharmaceutical and biotechnology industry, and receive analysis of each market and its applications, regulatory environment, technology involved, market projections and market share. Patents and their allotments in each category are discussed as well…

Use this report to:

  • Learn about the current and future characteristics of the global market for enzyme inhibitors
  • Identify current fields of application for enzyme inhibitors, with emphasis on the usage of the inhibitors in therapeutic categories and various disease sectors
  • Focus on the present and future strategies within the market for enzyme inhibitors
  • Learn about the strengths and weaknesses of each type in light of the new technologies, growing competition and changing customer needs.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

SUMMARY FIGURE
GLOBAL REVENUE OF ENZYME INHIBITORS MARKET, 2009-2016
($ MILLIONS)